Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biosimilar drug
|
| gptkbp:activeIngredient |
gptkb:adalimumab
|
| gptkbp:approvalYear |
2023
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
L04AB04
|
| gptkbp:countryOfOperation |
gptkb:European_Union
gptkb:United_States |
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Yuflyma
|
| gptkbp:indication |
gptkb:Crohn's_disease
gptkb:psoriatic_arthritis ulcerative colitis rheumatoid arthritis uveitis ankylosing spondylitis plaque psoriasis hidradenitis suppurativa |
| gptkbp:manufacturer |
gptkb:Celltrion
|
| gptkbp:product |
gptkb:Humira
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:bfsParent |
gptkb:adalimumab_(Humira)
|
| gptkbp:bfsLayer |
8
|